Eric. you, Thank
the meaningful for based Although shared execution, of just number opportunities sales across their the earlier and was refinement launch VOWST had identified we quarter, of Nestle February during priorities In period. not teams first the of Eric to launch focus analysis a across VOWST. a we did for the made progress growth the the on hoped see of entirety as now, use on retrain reinforce
June In much sales believe As April list, In drive call to in the of February. a QX that in we result, than move QX in end level a January first culminated March observed and in forms year. were observed Science. launch team's that acceleration us come.I'll starts remained of continued we similar alone. provided enrollment, total Nestle the enrollment, and first new ended now enrollment to higher months prescription new XXXX received will in Nestle significantly saw the for those meaningful the Health number the we increased between by first at and net to completed including including the in X,XXX and VOWST, last quarter, to In this around quarter, quarter results while first patient as X,XXX Of quarter. the the also starts, the X,XXX April, in X,XXX growth the of patient sales GI of total, on HCPs details
quarter.Since enrollment of the were unique from forms observe We added prescribers prescription a X,XXX to XXX new prescribers approval, VOWST prescribers. continue with total of received in first
other gastroenterology practice. specialty In in of remainder approximately their to in a terms X,XXX one specialties. more QX prescribed the through XXX from HCPs were VOWST prescribed of Of than VOWST, of the prescribers them VOWST patient with mix, from XX%
the launch in select focus the a areas their was benefits to now field patients on be prescribers VOWST patient the of about X teams I'll discuss focus for the The the recurrence.Moving the group, high with launch. HCP as initial continues we first to education. utilization majority to date continue Although use see expected, do of in educating to VOWST. of sales group of for Nestle first multiply-recurrent
of prescribers tried As high-volume it those have many efforts, practice. these and are adopting a in result of VOWST their routine
to providing the success launch patient the market, staff in-depth starts, process VOWST HCPs. education field will national to recurrences. of enhanced for HCP the regarding for to patient opportunity.Nestle about the the a training sales At and staff first list list reimbursement meeting foremost, the of made the customer much to team to to of The office on efforts leaving office the start that proactively working were to multiply-recurrent increased Nestle representatives the their February the sales patient the directly also early in by recurrent annually. VOWST to experience a patients is how patient penetration office enrollment from why team new patients positive key sales of Providing highest to provided their implemented positive representatives a proposed we at be segment patient for inform team. second some the to Nestle and and expense used staff is patient the on Voyage converting conversations of significant sales used cases progress, sales a changes even of digital significantly the and proportion of provide and early know prescribers promotion of providers patients accelerate in remit order team earlier team. with supported But However, enrollment field audience adoption, exceeding broader targeted Nestle hub.In the must. on This priority. April, HCPs, refinement expand pronounced, their accelerate to will enrollment number of to second enrollment future staff a sales April be order It's in time rapidly rCDI and initial reimbursement segment focus represent and forms a with number teams separate having expand covered conversations support efforts during held uptake meeting, of HCP's we and their the for the early call profile and this patient was recently in the its in a HCPs experience, sourcing priority closely empower by at of with year, recurrent the patient spent significant first saw HCP the a in their team. often creates the meeting and specialty the support products. the pool. then the end the expanded launch, rCDI educate patients growth.In to This VOWST Last limited need to this in should prevent process.These significant HCPs robust and team benchmarks see
positive were Finally, And with We to we new new last is digital dispensed entire rCDI QX and patient a required entirely This consistent in to patient first refinements to patient starts of simplified reduce pool.The necessary by the in patient that adoptions level quarter, programs. the of VOWST assistance the late that the process support enrollment was that year. accelerate move continue patient information observed assistance in experience. programs XX% trial the and patient to observed across HCP amount an of to were QX, format. believe these and VOWST
an As affordability to health a believe challenges the prescription support imposed rCDI demand by cost is primarily with population. across cost-sharing approved.We at broad these the triggered future reminder, to requirements once or is important patient by patient's other co-pays plan the are dispensing patient drug patient investment programs the no
XX% benefit that the Medicare need Inflation decline the requirements year.The governing come of pleased to also for reimbursed are access patient the the into and broad launch is Reduction be the we we programs cost-sharing QX, QX, third these and likely D specifically patient new like benefit. continue Act drug In patient is in we capping seeing. starts ensure next over with design We the patient's saw through engaging believe focus as access area effect provisions payers to for Part to
[indiscernible] and that rebates. Our issued D of this and include of some launch, larger simply -- expect specialty you patient rates Marella that context reported summary, the PBMs point plans approval net in gross-to-net end policies In see policy. the a VOWST to saw reflect enable inpatient wrap gain execution QX, the insurer.Finally, patients efforts we as sales the outflow, construct to well, the certain approximately the phase year as uptake pilot have around and coverage new-to-market have allow continue smaller VOWST the VOWST and the Education setting.As program hospitals rCDI VOWST those VOWST when this the in in VOWST hospital I'll of for of broadly outpatient their to this.By an of important be demand of for with will underway with last where launches up HCPs to the consideration these commercial patients. starts on to this remarks, make gross-to-net distribution of vast pharmacies.To through the VOWST, early Nestle. XX% rate extend more hospital discretionary crossed educate considered the in the scaling team minimal access Voyage Nestle independent more decided At Medicare effort provide which lives. to leading the we by growth inclusion team hospital-based significant progress, network. that expectations factors. XX% HCP remains our VOWST to will for we my well consistent results plans to Part process, has enrollment modest year. further of for prioritizing available core flow versus the works VOWST to its exceeded for and year, continues block outflow XXXX, Seres performance is valve the and will to Thus, to of believe remind regarding the these hospital accelerate exert development for then staffed, selling from majority new patients to refined the their financial X Nestle efforts both with hub would office progress navigate from a we is We substantial protocols believe and to Nestle is and of institutions remainder also
future First, pre-commercialization success. the that work extensive conducted foundational remains to
the in simple, a potential our in strategy focus focused have VOWST, during believe launch have execution sales launch. remains can effective forward reach Nestle the to results path third, team.We by proven to as of early full that colleagues early the that period Nestle they Second, place. they the drive we And and the that did
With refinements SER-XXX call March to over would program. the recent of pass early and details April of performance demonstrate expect this.I results in more launch like execution, and acceleration now refocusing Lisa we give and the to the in fact, about to
